Acetylcholinesterase activity in cerebrospinal fluid of patients with Alzheimer's disease and senile dementia
- PMID: 3760912
- DOI: 10.1016/0022-510x(86)90096-1
Acetylcholinesterase activity in cerebrospinal fluid of patients with Alzheimer's disease and senile dementia
Abstract
Acetylcholinesterase (AChE) in the cerebrospinal fluid (CSF) from patients with Alzheimer-type dementia and control subjects was analyzed by centrifugation on a sucrose density gradient, and by column chromatography on Sephadex G-200. The sedimentation coefficient and molecular weight of CSF AChE were calculated as 10S and 380,000, respectively, which corresponded to those of G4 isozyme in the brain. Other isozymes of AChE were not detected in the CSF of either patients with Alzheimer-type dementia or the controls. Sufficient activity of AChE was observed in the CSF of a patient with familial pseudocholinesterase deficiency, although the pseudocholinesterase activity was not found either in the serum or in the CSF. CSF AChE activity in control subjects increased with advancing age (P less than 0.02). AChE activity in the CSF was significantly lower in patients with presenile dementia (Alzheimer's disease), compared with age-matched control subjects (P less than 0.001). However, AChE activity in the CSF showed a wide variation among patients of Alzheimer-type dementia with a late onset (senile dementia).
Similar articles
-
Acetylcholinesterase and butyrylcholinesterase activities in cerebrospinal fluid from different levels of the neuraxis of patients with dementia of the Alzheimer type.J Neurol Neurosurg Psychiatry. 1992 Nov;55(11):1074-8. doi: 10.1136/jnnp.55.11.1074. J Neurol Neurosurg Psychiatry. 1992. PMID: 1469405 Free PMC article.
-
Cholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type.Brain. 1987 Oct;110 ( Pt 5):1309-22. doi: 10.1093/brain/110.5.1309. Brain. 1987. PMID: 3676702
-
Cerebrospinal fluid acetylcholinesterase activity in senile dementia of the Alzheimer type.Ann Neurol. 1985 Jan;17(1):46-8. doi: 10.1002/ana.410170111. Ann Neurol. 1985. PMID: 3985585
-
Acetylcholinesterase in Alzheimer's disease.Mech Ageing Dev. 2001 Nov;122(16):1961-9. doi: 10.1016/s0047-6374(01)00309-8. Mech Ageing Dev. 2001. PMID: 11589914 Review.
-
Brain and cerebrospinal fluid cholinesterases in Alzheimer's disease, Parkinson's disease and aging. A critical review of clinical and experimental studies.J Neural Transm Park Dis Dement Sect. 1992;4:337-58. doi: 10.1007/BF02260081. J Neural Transm Park Dis Dement Sect. 1992. PMID: 1388703 Review.
Cited by
-
Cholinesterases in the cerebrospinal fluid, plasma, and erythrocytes of patients with Alzheimer's disease.J Neural Transm. 1989;75(2):119-27. doi: 10.1007/BF01677425. J Neural Transm. 1989. PMID: 2918304
-
Preferential inhibition of acetylcholinesterase molecular forms in rat brain.Neurochem Res. 1992 May;17(5):489-95. doi: 10.1007/BF00969897. Neurochem Res. 1992. PMID: 1528356
-
Acetylcholinesterase and butyrylcholinesterase activities in cerebrospinal fluid from different levels of the neuraxis of patients with dementia of the Alzheimer type.J Neurol Neurosurg Psychiatry. 1992 Nov;55(11):1074-8. doi: 10.1136/jnnp.55.11.1074. J Neurol Neurosurg Psychiatry. 1992. PMID: 1469405 Free PMC article.
-
Acetylcholine synthesis in human CSF: implications for study of central cholinergic metabolism.Neurochem Res. 1989 Feb;14(2):191-6. doi: 10.1007/BF00969638. Neurochem Res. 1989. PMID: 2725819
-
Mixed-effect circadian rhythm model for human erythrocyte acetylcholinesterase activity--application to the proof of concept of cholinesterase inhibition by acorn extract in healthy subjects with galantamine as positive control.Eur J Clin Pharmacol. 2012 May;68(5):599-605. doi: 10.1007/s00228-011-1192-3. Epub 2011 Dec 30. Eur J Clin Pharmacol. 2012. PMID: 22207414 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical